Literature DB >> 11956921

Cytokines and growth factors in the protruded intervertebral disc of the lumbar spine.

Nicola Specchia1, Alessia Pagnotta, Amelia Toesca, Francesco Greco.   

Abstract

Nerve root irritation induced by factors produced by the intervertebral disc may play a crucial role in the pathophysiology of sciatic pain production. In this study we used immunohistochemistry to investigate the presence of transforming growth factor-beta1 (TGF-beta1), insulin-like growth factor-1 (IGF-1), interleukin-6 (IL-6), IL-6-receptor (IL-6R) and fibronectin in lumbar disc bioptic specimens from 30 patients with disc herniation (protrusion type). Chondrocytes of herniated discs stained positive for TGF-beta1, IGF-1, IL-6 and fibronectin. We demonstrated for the first time the presence of IL-6-R in the chondrocytes of herniated tissue. Specimens from autoptic healthy tissue were used as controls. In these sections no immunoreaction for TGF-beta1, IL-6, or IL-6R was found, while they expressed IGF-1 and fibronectin, but in lower quantities than herniated discs. These results demonstrated the production of factors such as TGF-beta1, IGF-1, IL-6, IL-6R and fibronectin at the site of lumbar disc herniation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956921      PMCID: PMC3610507          DOI: 10.1007/s00586-001-0361-y

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  36 in total

Review 1.  The applications of buckminsterfullerene C60 and derivatives in orthopaedic research.

Authors:  Qihai Liu; Quanjun Cui; Xudong Joshua Li; Li Jin
Journal:  Connect Tissue Res       Date:  2014-01-24       Impact factor: 3.417

Review 2.  Biological treatment strategies for disc degeneration: potentials and shortcomings.

Authors:  Günther Paesold; Andreas G Nerlich; Norbert Boos
Journal:  Eur Spine J       Date:  2006-09-16       Impact factor: 3.134

3.  Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues.

Authors:  Mohammed F Shamji; Lori A Setton; Wingrove Jarvis; Stephen So; Jun Chen; Liufang Jing; Robert Bullock; Robert E Isaacs; Christopher Brown; William J Richardson
Journal:  Arthritis Rheum       Date:  2010-07

4.  PDGF, bFGF and IGF-I stimulate the proliferation of intervertebral disc cells in vitro via the activation of the ERK and Akt signaling pathways.

Authors:  Harris Pratsinis; Dimitris Kletsas
Journal:  Eur Spine J       Date:  2007-09-01       Impact factor: 3.134

5.  Multiplex Epigenome Editing of Dorsal Root Ganglion Neuron Receptors Abolishes Redundant Interleukin 6, Tumor Necrosis Factor Alpha, and Interleukin 1β Signaling by the Degenerative Intervertebral Disc.

Authors:  Joshua D Stover; Niloofar Farhang; Brandon Lawrence; Robby D Bowles
Journal:  Hum Gene Ther       Date:  2019-06-11       Impact factor: 5.695

Review 6.  Nucleus pulposus tissue engineering: a brief review.

Authors:  Xinlin Yang; Xudong Li
Journal:  Eur Spine J       Date:  2009-07-15       Impact factor: 3.134

7.  Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study.

Authors:  S Genevay; S Stingelin; C Gabay
Journal:  Ann Rheum Dis       Date:  2004-04-28       Impact factor: 19.103

8.  Expression of fibronectin and TGF-beta1 mRNA and protein suggest altered regulation of extracellular matrix in degenerated disc tissue.

Authors:  Andreas G Nerlich; Beatrice E Bachmeier; Norbert Boos
Journal:  Eur Spine J       Date:  2004-09-01       Impact factor: 3.134

9.  Longitudinal study of vertebral type-1 end-plate changes on MR of the lumbar spine.

Authors:  D Mitra; V N Cassar-Pullicino; I W McCall
Journal:  Eur Radiol       Date:  2004-04-02       Impact factor: 5.315

Review 10.  Cardiovascular and lifestyle risk factors in lumbar radicular pain or clinically defined sciatica: a systematic review.

Authors:  Rahman Shiri; Jaro Karppinen; Päivi Leino-Arjas; Svetlana Solovieva; Helena Varonen; Eija Kalso; Olavi Ukkola; Eira Viikari-Juntura
Journal:  Eur Spine J       Date:  2007-05-25       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.